questionsmedicales.fr
Maladies de l'appareil digestif
Maladies du foie
Hépatite
Hépatites virales humaines
Hépatites virales humaines : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Hépatite virale
Tests de laboratoire
Hépatite C
Polymerase Chain Reaction
Symptômes
5
Hépatite B
Douleur abdominale
Hépatite C
Symptômes chroniques
Asymptomatique
Hépatite virale
Prévention
5
Hygiène
Hépatites virales
Traitements
5
Hépatite C
Traitement antiviral
Complications
5
Hépatite C
Insuffisance hépatique
Cancer du foie
Hépatites virales
Facteurs de risque
5
Hépatite B
Facteurs de risque
Hépatite C
Drogues injectables
Travailleurs de la santé
Hépatites virales
Immunodépression
Hépatites virales
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hépatites virales humaines : Questions médicales les plus fréquentes",
"headline": "Hépatites virales humaines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hépatites virales humaines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-11",
"dateModified": "2025-04-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hépatites virales humaines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Hépatite",
"url": "https://questionsmedicales.fr/mesh/D006505",
"about": {
"@type": "MedicalCondition",
"name": "Hépatite",
"code": {
"@type": "MedicalCode",
"code": "D006505",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C06.552.380"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hépatite A",
"alternateName": "Hepatitis A",
"url": "https://questionsmedicales.fr/mesh/D006506",
"about": {
"@type": "MedicalCondition",
"name": "Hépatite A",
"code": {
"@type": "MedicalCode",
"code": "D006506",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C06.552.380.705.422"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hépatite B",
"alternateName": "Hepatitis B",
"url": "https://questionsmedicales.fr/mesh/D006509",
"about": {
"@type": "MedicalCondition",
"name": "Hépatite B",
"code": {
"@type": "MedicalCode",
"code": "D006509",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C06.552.380.705.437"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hépatite C",
"alternateName": "Hepatitis C",
"url": "https://questionsmedicales.fr/mesh/D006526",
"about": {
"@type": "MedicalCondition",
"name": "Hépatite C",
"code": {
"@type": "MedicalCode",
"code": "D006526",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C06.552.380.705.440"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hépatite D",
"alternateName": "Hepatitis D",
"url": "https://questionsmedicales.fr/mesh/D003699",
"about": {
"@type": "MedicalCondition",
"name": "Hépatite D",
"code": {
"@type": "MedicalCode",
"code": "D003699",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C06.552.380.705.450"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hépatite E",
"alternateName": "Hepatitis E",
"url": "https://questionsmedicales.fr/mesh/D016751",
"about": {
"@type": "MedicalCondition",
"name": "Hépatite E",
"code": {
"@type": "MedicalCode",
"code": "D016751",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C06.552.380.705.470"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Hépatites virales humaines",
"alternateName": "Hepatitis, Viral, Human",
"code": {
"@type": "MedicalCode",
"code": "D006525",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Robert Thimme",
"url": "https://questionsmedicales.fr/author/Robert%20Thimme",
"affiliation": {
"@type": "Organization",
"name": "Klinik für Innere Medizin II - Gastroenterologie, Hepatologie, Endokrinologie, Infektiologie, Universitätsklinikum Freiburg, Freiburg, Deutschland. robert.thimme@uniklinik-freiburg.de."
}
},
{
"@type": "Person",
"name": "Fabien Zoulim",
"url": "https://questionsmedicales.fr/author/Fabien%20Zoulim",
"affiliation": {
"@type": "Organization",
"name": "INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon, Lyon, France."
}
},
{
"@type": "Person",
"name": "Emmanuelle Jouanguy",
"url": "https://questionsmedicales.fr/author/Emmanuelle%20Jouanguy",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale (INSERM) UMR-1163, Necker Hospital for Sick Children, Paris, France. emmanuelle.jouanguy@inserm.fr."
}
},
{
"@type": "Person",
"name": "Christoph Neumann-Haefelin",
"url": "https://questionsmedicales.fr/author/Christoph%20Neumann-Haefelin",
"affiliation": {
"@type": "Organization",
"name": "Klinik für Innere Medizin II - Gastroenterologie, Hepatologie, Endokrinologie, Infektiologie, Universitätsklinikum Freiburg, Freiburg, Deutschland."
}
},
{
"@type": "Person",
"name": "C-Thomas Bock",
"url": "https://questionsmedicales.fr/author/C-Thomas%20Bock",
"affiliation": {
"@type": "Organization",
"name": "Division of Viral Gastroenteritis and Hepatitis Pathogens and Enteroviruses, Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany. BockC@rki.de."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Understanding Prognosis: Discrepancy in Prognosis Estimates Between Patients With Cirrhosis and their Hepatologists.",
"datePublished": "2022-05-26",
"url": "https://questionsmedicales.fr/article/35643416",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cgh.2022.04.042"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prognosis of naevoid melanomas.",
"datePublished": "2023-10-09",
"url": "https://questionsmedicales.fr/article/37832354",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.prp.2023.154881"
}
},
{
"@type": "ScholarlyArticle",
"name": "The direct prognosis comparison of",
"datePublished": "2023-06-02",
"url": "https://questionsmedicales.fr/article/37268989",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s40001-023-01140-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Clinicopathological characteristics and prognosis of medullary thyroid microcarcinoma: a tumor with a similar prognosis to macrocarcinoma.",
"datePublished": "2023-11-28",
"url": "https://questionsmedicales.fr/article/38017592",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s40001-023-01534-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "A retrospective study on the clinical characteristics and prognosis of alopecia totalis and universalis: An update on prognosis.",
"datePublished": "2023-05-19",
"url": "https://questionsmedicales.fr/article/37208851",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/1346-8138.16840"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies de l'appareil digestif",
"item": "https://questionsmedicales.fr/mesh/D004066"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies du foie",
"item": "https://questionsmedicales.fr/mesh/D008107"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hépatite",
"item": "https://questionsmedicales.fr/mesh/D006505"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hépatites virales humaines",
"item": "https://questionsmedicales.fr/mesh/D006525"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hépatites virales humaines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hépatites virales humaines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-04-29",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hépatites virales humaines",
"description": "Comment diagnostiquer une hépatite virale ?\nQuels tests sont utilisés pour l'hépatite B ?\nPeut-on diagnostiquer l'hépatite C par PCR ?\nQuels sont les signes d'une hépatite aiguë ?\nL'échographie est-elle utile pour l'hépatite ?",
"url": "https://questionsmedicales.fr/mesh/D006525?mesh_terms=Prognosis#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hépatites virales humaines",
"description": "Quels sont les symptômes de l'hépatite A ?\nL'hépatite B provoque-t-elle des douleurs abdominales ?\nQuels symptômes indiquent une hépatite C chronique ?\nL'hépatite D a-t-elle des symptômes spécifiques ?\nPeut-on avoir des symptômes sans hépatite ?",
"url": "https://questionsmedicales.fr/mesh/D006525?mesh_terms=Prognosis#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hépatites virales humaines",
"description": "Comment prévenir l'hépatite A ?\nQuelles mesures pour éviter l'hépatite B ?\nLe vaccin contre l'hépatite C existe-t-il ?\nComment se protéger contre l'hépatite D ?\nL'hygiène peut-elle prévenir l'hépatite ?",
"url": "https://questionsmedicales.fr/mesh/D006525?mesh_terms=Prognosis#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hépatites virales humaines",
"description": "Quel est le traitement de l'hépatite A ?\nComment traiter l'hépatite B chronique ?\nL'hépatite C se traite-t-elle efficacement ?\nY a-t-il un vaccin pour l'hépatite B ?\nQuels sont les traitements pour l'hépatite D ?",
"url": "https://questionsmedicales.fr/mesh/D006525?mesh_terms=Prognosis#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hépatites virales humaines",
"description": "Quelles complications peuvent survenir avec l'hépatite B ?\nL'hépatite C peut-elle causer des problèmes hépatiques ?\nQuelles sont les conséquences de l'hépatite A ?\nL'hépatite D aggrave-t-elle d'autres hépatites ?\nPeut-on développer un cancer du foie avec l'hépatite ?",
"url": "https://questionsmedicales.fr/mesh/D006525?mesh_terms=Prognosis#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hépatites virales humaines",
"description": "Quels sont les facteurs de risque pour l'hépatite B ?\nQui est à risque d'hépatite C ?\nL'hépatite A est-elle liée à des voyages ?\nLes travailleurs de la santé sont-ils à risque d'hépatite ?\nLes personnes immunodéprimées sont-elles plus à risque ?",
"url": "https://questionsmedicales.fr/mesh/D006525?mesh_terms=Prognosis#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une hépatite virale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sanguins pour détecter les marqueurs viraux et les enzymes hépatiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour l'hépatite B ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests HBsAg, anti-HBs et anti-HBc sont couramment utilisés pour l'hépatite B."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer l'hépatite C par PCR ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la PCR détecte l'ARN du virus de l'hépatite C dans le sang, confirmant l'infection."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'une hépatite aiguë ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent jaunisse, fatigue, douleurs abdominales et nausées."
}
},
{
"@type": "Question",
"name": "L'échographie est-elle utile pour l'hépatite ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'échographie peut évaluer l'état du foie et détecter des anomalies."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de l'hépatite A ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, fièvre, nausées, et jaunisse."
}
},
{
"@type": "Question",
"name": "L'hépatite B provoque-t-elle des douleurs abdominales ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs dans la partie supérieure droite de l'abdomen peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une hépatite C chronique ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue persistante, douleurs articulaires et jaunisse peuvent indiquer une hépatite C chronique."
}
},
{
"@type": "Question",
"name": "L'hépatite D a-t-elle des symptômes spécifiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes sont similaires à ceux de l'hépatite B, mais peuvent être plus graves."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans hépatite ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes peuvent être asymptomatiques malgré une infection virale."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'hépatite A ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination et l'hygiène alimentaire sont essentielles pour prévenir l'hépatite A."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour éviter l'hépatite B ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des préservatifs et éviter le partage d'aiguilles sont des mesures clés."
}
},
{
"@type": "Question",
"name": "Le vaccin contre l'hépatite C existe-t-il ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccin efficace contre l'hépatite C."
}
},
{
"@type": "Question",
"name": "Comment se protéger contre l'hépatite D ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination contre l'hépatite B protège également contre l'hépatite D."
}
},
{
"@type": "Question",
"name": "L'hygiène peut-elle prévenir l'hépatite ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une bonne hygiène des mains et des aliments réduit le risque d'hépatites virales."
}
},
{
"@type": "Question",
"name": "Quel est le traitement de l'hépatite A ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement spécifique ; le repos et l'hydratation sont recommandés."
}
},
{
"@type": "Question",
"name": "Comment traiter l'hépatite B chronique ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antiviraux comme l'entécavir ou le ténofovir sont utilisés pour contrôler l'infection."
}
},
{
"@type": "Question",
"name": "L'hépatite C se traite-t-elle efficacement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traitements antiviraux à action directe peuvent guérir l'hépatite C dans la plupart des cas."
}
},
{
"@type": "Question",
"name": "Y a-t-il un vaccin pour l'hépatite B ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vaccin contre l'hépatite B est efficace pour prévenir l'infection."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements pour l'hépatite D ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement de l'hépatite D est limité ; l'interféron peut être utilisé dans certains cas."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'hépatite B ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la cirrhose et le cancer du foie."
}
},
{
"@type": "Question",
"name": "L'hépatite C peut-elle causer des problèmes hépatiques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'hépatite C peut entraîner une cirrhose et une insuffisance hépatique."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences de l'hépatite A ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hépatite A est généralement bénigne, mais peut causer des complications rares comme l'insuffisance hépatique."
}
},
{
"@type": "Question",
"name": "L'hépatite D aggrave-t-elle d'autres hépatites ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'hépatite D peut aggraver l'hépatite B, augmentant le risque de complications."
}
},
{
"@type": "Question",
"name": "Peut-on développer un cancer du foie avec l'hépatite ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections chroniques par l'hépatite B ou C augmentent le risque de cancer du foie."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour l'hépatite B ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le partage d'aiguilles, les rapports sexuels non protégés et la transfusion sanguine."
}
},
{
"@type": "Question",
"name": "Qui est à risque d'hépatite C ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes ayant des antécédents de consommation de drogues injectables sont à risque élevé."
}
},
{
"@type": "Question",
"name": "L'hépatite A est-elle liée à des voyages ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones à forte prévalence d'hépatite A augmente le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les travailleurs de la santé sont-ils à risque d'hépatite ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont exposés à un risque accru d'hépatite B et C par contact avec le sang."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles plus à risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont plus susceptibles de développer des infections hépatiques graves."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 07/04/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Klinik für Innere Medizin II - Gastroenterologie, Hepatologie, Endokrinologie, Infektiologie, Universitätsklinikum Freiburg, Freiburg, Deutschland. robert.thimme@uniklinik-freiburg.de.
Publications dans "Hépatites virales humaines" :
3 publications dans cette catégorie
Affiliations :
INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon, Lyon, France.
Publications dans "Hépatites virales humaines" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale (INSERM) UMR-1163, Necker Hospital for Sick Children, Paris, France. emmanuelle.jouanguy@inserm.fr.
Imagine Institute, Paris University, Paris, France. emmanuelle.jouanguy@inserm.fr.
St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY, USA. emmanuelle.jouanguy@inserm.fr.
Publications dans "Hépatites virales humaines" :
2 publications dans cette catégorie
Affiliations :
Klinik für Innere Medizin II - Gastroenterologie, Hepatologie, Endokrinologie, Infektiologie, Universitätsklinikum Freiburg, Freiburg, Deutschland.
Publications dans "Hépatites virales humaines" :
2 publications dans cette catégorie
Affiliations :
Division of Viral Gastroenteritis and Hepatitis Pathogens and Enteroviruses, Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany. BockC@rki.de.
Institute of Tropical Medicine, University of Tübingen, Tubingen, Germany. BockC@rki.de.
Publications dans "Hépatites virales humaines" :
2 publications dans cette catégorie
Affiliations :
Departments of Laboratory Medicine and Infectious Diseases and Obstetrics & Gynecology, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China. Electronic address: zgr03summer@126.com.
Publications dans "Hépatites virales humaines" :
2 publications dans cette catégorie
Affiliations :
Liver Unit, Hospital Universitario Valle Hebron and Civerehd del Instituto Carlos III, Barcelona, Spain.
Publications dans "Hépatites virales humaines" :
2 publications dans cette catégorie
Affiliations :
Department of Internal Medicine 1, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
Publications dans "Hépatites virales humaines" :
2 publications dans cette catégorie
Affiliations :
Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham Heersink School of Medicine, 1917 Clinic Dewberry, 3220 5th Avenue South, Room 1044A, Birmingham, AL 35222, USA. Electronic address: rfranco@uabmc.edu.
Publications dans "Hépatites virales humaines" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine II, University Hospital Freiburg, Freiburg, Germany.
IMM-PACT Clinician Scientist Programme, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Publications dans "Hépatites virales humaines" :
2 publications dans cette catégorie
Affiliations :
Emergency Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Publications dans "Hépatites virales humaines" :
2 publications dans cette catégorie
Affiliations :
Microbiology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
CIBEREHD, Instituto de Salud Carlos III, Madrid, Spain.
Publications dans "Hépatites virales humaines" :
2 publications dans cette catégorie
Affiliations :
CIBEREHD, Instituto de Salud Carlos III, Madrid, Spain.
Biochemistry Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Publications dans "Hépatites virales humaines" :
2 publications dans cette catégorie
Affiliations :
Liver Unit, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
CIBEREHD, Instituto de Salud Carlos III, Madrid, Spain.
Publications dans "Hépatites virales humaines" :
2 publications dans cette catégorie
Affiliations :
Liver Unit, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
CIBEREHD, Instituto de Salud Carlos III, Madrid, Spain.
Publications dans "Hépatites virales humaines" :
2 publications dans cette catégorie
Affiliations :
Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan.
Publications dans "Hépatites virales humaines" :
1 publication dans cette catégorie
Affiliations :
St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY.
Publications dans "Hépatites virales humaines" :
1 publication dans cette catégorie
Affiliations :
Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY.
Publications dans "Hépatites virales humaines" :
1 publication dans cette catégorie
Affiliations :
Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.
Paris Descartes University, Imagine Institute, Paris, France.
Publications dans "Hépatites virales humaines" :
1 publication dans cette catégorie
Affiliations :
Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY.
Publications dans "Hépatites virales humaines" :
Patients require a clear understanding of their prognosis to make informed decisions about their care. The aim of this study was to compare the perceptions of prognosis and transplant candidacy betwee...
Patients with cirrhosis and their hepatologists were prospectively recruited at an urban liver transplant center. Patients and hepatologists were asked about transplant candidacy and about how many ye...
Seventy patients and 6 hepatologists were enrolled in the study. Patients were predominantly male (61.4%) and white (68.6%), with a mean MELD-Na score of 19 ± 9. There was no-slight agreement between ...
Patients with cirrhosis are more optimistic and less accurate in their predictions of survival compared with hepatologists, although they are more realistic about their transplant candidacy. Aligning ...
There appear to be several variants of naevoid melanoma suspected as having different outcomes, but follow-up studies have been few. We aimed to assess the prognosis of naevoid melanomas in a multi-ce...
From histopathology records we ascertained patients in the UK, Australia and Italy diagnosed with maturing naevoid melanoma (n = 65; 14; 7 respectively) and nodular/papillomatous naevoid melanoma (12;...
Among UK patients, there was a non-significantly lower risk of melanoma death in maturing naevoid vs SSM, including after accounting for competing causes of death (SHR 0.40, 95% confidence interval (C...
There was no significant difference in risk of death from melanomas with naevoid features, and SSM. Nodular/ papillomatous naevoid melanoma patients did not carry higher risk of death than SSM patient...
This study aims to compare the clinical outcomes after performing radical prostatectomy (RP) or low-dose-rate brachytherapy (LDR) for patients with intermediate-risk prostate cancer (IRPC)....
We performed a retrospective analysis on 361 IRPC patients who underwent treatment in Peking Union Medical College Hospital from January 2014 to August 2021, of which 160 underwent RP and 201 underwen...
Median follow-up was 54 months for RP and 69 months for LDR. According to log-rank test, the differences of 5-year bRFS (70.2% vs 83.2%, P = 0.003) and 8-year bRFS (63.1% vs 68.9%, P < 0.001) between ...
LDR is a reasonable treatment option for IRPC patients, yielding improved bRFS and equivalent rates of cRFS, CSS and OS when compared with RP....
Tumor size plays an important role in the staging and treatment of thyroid carcinoma. A tumor with a maximum diameter of 1 cm or less is referred to as microcarcinoma. It is unclear if the clinicopath...
The patients with medullary thyroid carcinoma underwent radical operation at our hospital between December 2000 and January 2022 were retrospectively studied. A database was established for this study...
A total of 198 patients were included. Of them, 56 and 142 with MTMC and macrocarcinoma, respectively. Few patients in the MTMC group had lateral lymph node metastasis. One hundred and seventy-eight (...
Patients with MTMC have a lower risk of lateral lymph node metastasis and better disease-free survival than those with macrocarcinoma. However, there was no significant difference in the overall survi...
Alopecia totalis (AT) and alopecia universalis (AU) is known to have a poor prognosis with high relapse rate, and treatment failure is observed in most patients, regardless of the type of therapy. Alt...
Immune and stromal cells contribute to glioma progression by infiltrating the tumor microenvironment. We used clinical characteristics, RNA sequencing data and the ESTIMATE algorithm to obtain stromal...
Prognostic studies are investigations to estimate the risk or probability of future outcomes in people with established disease. Ideally based on cohort studies where it is established: the time of on...
Cholangiocarcinoma (CHOL) is a malignant tumor that originates in the extrahepatic bile duct and can extend from the hilar region to the lower end of the common bile duct. The prognosis of CHOL patien...
The TCGA-CHOL dataset was applied to obtain and analyze the coexpression of 1281 m...
Kaplan-Meier analysis indicated poor overall survival (OS) for the high-risk group. Two Gene Expression Omnibus (GEO) datasets (GSE89748 and GSE107943) were used to validate the risk model. The result...
Our findings suggest that this model can be a prognostic indicator for CHOL patients....
Head and neck squamous cell carcinoma (HNSCC), the most common head and neck cancer, is highly aggressive and heterogeneous, resulting in variable prognoses and immunotherapeutic outcomes. Natural kil...
In this study, NRGs were used to classify HNSCC from the TCGA-HNSCC and GEO cohorts. The genes were evaluated using univariate cox regression analysis based on the differential analysis of normal and ...
With the TCGA-HNSCC data, we established a nomogram based on the 17-NRGs signature and a variety of clinicopathological characteristics. The low-risk group exhibited a better effect when it came to im...
17-NRGs signature and nomograms demonstrate excellent predictive performance and offer new perspectives for assessing pre-immune efficacy, which will facilitate future precision immuno-oncology resear...
Genetics plays a significant role in determining an individual's susceptibility to dental diseases, the response to dental treatments, and the overall prognosis of dental interventions. Here, the auth...